Clinical trial
111In-ch806 in Patients With Advanced Tumours Expressing the 806 Antigen
NCT00291447 · Ludwig Institute for Cancer Research, Other · Completed
Key facts
| NCT number | NCT00291447 |
|---|---|
| Title | 111In-ch806 in Patients With Advanced Tumours Expressing the 806 Antigen |
| Official title | A Phase 1 Single Dose Escalation Trial of ch806 in Patients With Advanced Tumours Expressing the 806 Antigen |
| Lead sponsor | Ludwig Institute for Cancer Research, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Biological |
| Interventions | ch806 |
| Enrollment | 8 |
| Start date | May 1, 2005 |
| Primary completion | Feb 16, 2006 |
| Completion | Aug 10, 2006 |
| First posted | Feb 14, 2006 |
| Last update posted | Oct 10, 2022 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: